Kansas pilot program to use electronic medical records to coordinate care

A health information technology project "may revolutionize how health care is managed" by using medical records to coordinate patients' records. The Kansas City Star reports: "A pilot program is helping 13 area doctors' offices convert to doing that for their patients. The two-year program, backed by Blue Cross and Blue Shield of Kansas City and Leawood-based TransforMED, involves 13 primary care, family practice and pediatric medical practices. ... And by the time the study is complete, Blue Cross has pledged to change the way it compensates those doctors."

"Advocates say patients will get better, more efficient care if their primary care doctor, leading a team of other providers, takes a leading role in ushering them through the health care system. ... The system also relies on adopting electronic medical records to help multiple doctors share patient information and reduce redundant tests or treatments. Blue Cross officials said they were committed to investing more than $1 million in the project over the next two years" (King, 11/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024